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Cardiotonic steroidWe show in the present work that the infrared (IR) spectrum of human PC-3 prostate cancer cells exposed to
anticancer drugs could offer a unique opportunity to get a ﬁngerprint of all the major biochemical
components (DNA, RNA, proteins, lipids, etc.) present in the cells and to identify with high sensitivity the
signature of the metabolic changes induced by anticancer drugs.
We investigated here the FTIR-related signatures of the effect of 4 structurally-related cardiotonic steroids
(CS), i.e. ouabain, 19-hydroxy-2″-oxovoruscharin, hellebrin and 19-hydroxy-hellebrin on PC-3 cancer cells
incubated between 0 and 36 h in the absence (control) or the presence of the CS. For each molecule a single
spectral signature described the largest part of the time dependent modiﬁcations with a possible very minor
second component. The spectral signatures characterizing the effects of each of the four CS were unique but
very similar when compared to the signature of the effect of an intercalating anticancer drug, i.e.
doxorubicin, selected as a positive reference compound in our study, suggesting a fully distinct set of cellular
perturbations. The current study thus illustrates that Fourier Transform Infrared (FTIR) analyses can be used
to identify, among the perturbations induced on a given cancer cell line, the features common to a group of
anticancer compounds as well as features speciﬁc to every single drug.frared; CS, cardiotonic steroid;
nent; ESS, Error sum of square
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A growing number of potential anticancer agents fails in the course
of drug development process suggesting that the selection procedure
for progression of molecules from early research stages through pre-
clinical trials to the clinic requires signiﬁcant improvement [1]. High
throughput screening procedures remain essentially based either on
the ability of new drugs to induce cell death over a panel of several cell
lines or on their interaction with key parts of one or several biological
pathways [1,2]. A technique able to provide a global ﬁngerprint of
drug mechanism of action on cancer cells could be of great interest in
the development of therapeutic medicines with new modes of action.
We suggest in the present study that the infrared (IR) spectrum of
tumor cells exposed to anticancer drugs could offer a uniqueopportunity to get a signature of all the major biochemical
components present in the cells and to characterize, with a high
sensitivity, speciﬁc metabolic changes induced by new potential
anticancer drugs.
Cardiotonic steroids (CS) are well known inotropic drugs for the
treatment of congestive heart failure and atrial arrhythmia, and the
mechanism of their positive inotropic effect is well characterized [3–6].
Chemically, CS are compounds presenting a steroid nucleuswith a lactone
moiety at position 17 [3,4]. Glycosylated CS contain a sugar moiety at
position 3 [3,4]. The nature of the lactone ring at position 17 deﬁnes the
class of CS: the cardenolides (with anunsaturatedbutyrolactone ring) and
the bufadienolides (with a α-pyrone ring) [3,4]. Recent studies
emphasized potent in vitro and in vivo antitumoral effects of these
molecules (reviewed in [3–5]). TheNa+/K+-ATPase, the so-called sodium
pump, is an integral transmembraneprotein found inall higher eukaryotic
cells that uses energy fromATP hydrolysis tomaintain a high K+ and low
Na+ concentration in the cytoplasm [7]. Recently a non pumping pool of
Na+/K+-ATPase had been evidenced and localised in caveolae [8], a raft
like structure [9]. This pool ofNa+/K+-ATPasewas showntobeassociated
with different signalling proteins and act as a signal transducer [10–12].
The sodium pump mediates CS-induced effects in a compound,
concentration and cell type-speciﬁc manner [3,4,13,14]. Exciting recent
ﬁndings have suggested additional signaling modes of action of the
sodium pump, implicating CS in the regulation of several important
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these compounds in various diseases, including cancer [3–6]. The
increased susceptibility of cancer cells to these compounds supports
their potential use as anticancer therapies, and the ﬁrst generation of
glycoside-based anticancer drugs are currently in clinical trials [3–6]. In
addition, we have previously demonstrated that cardenolides are able to
overcome MDR phenotype in cancer cells [15] as well as the intrinsic
resistance of various types of cancers to apoptosis [16,17]. We have
demonstrated that cardenolides exert in fact their anticancer activity
through the targeting of the alpha subunits of the sodium pump [18] and
that the alpha-1 subunit of the sodium pump is overexpressed in a large
proportion of non-small-cell lung cancers [18], glioblastoma [16] and
melanoma [19]. Because of their closely related structure and action, the
CS family is particularly challenging when distinct modes of action are to
be identiﬁed.
FTIR spectroscopy was used successfully for decades as label free
technique for the study of cells [20,21] as well as tissues [22–24].
Absence of reagent remains one of the main advantages of IR
spectroscopy among other exploratory techniques such as ﬂuores-
cence or microarrays. It senses every metabolite of the cells with a
great sensitivity without disturbing its integrity and can therefore
provide an accurate ﬁngerprint of modiﬁcations occurring within the
cells. In turn, IR spectroscopy can be used for bacteria or yeast typing
at strain level [20,25,26]. With human samples, IR spectroscopy
allowed rapid distinction between tumor and normal tissues [27–29]
or powerful discrimination between cancer cell lines [30]. For
example, our group established IR markers for determination of the
in vivo aggressiveness level of glioma cell lines [30]. Recently, we
evidenced that metabolic perturbations induced by ouabain on the
human PC-3 prostate cancer cell line at nM concentration can be
monitored by infrared spectroscopy [31]. In the present study, we
analyzed spectra of this human PC-3 prostate cancer cell line treated
with four different CS during 5 different periods of time. Two of these
CS are cardenolides and the remaining two bufadienolides. Each pair
of cardenolides and bufadienolides included one natural and one
hemisynthetic compound reduced in position 19 of the steroid
nucleus (see Fig. 1). As indicated above, CS share a common cellular
receptor, the Na+/K+-ATPase, but their mechanisms of anticancer
action might vary markedly from one compound to another [4,16,32].Fig. 1. Structure of cardiotonic steroids used in this study. A: Ouabain, B: 19-hydroxy-2″-oxov
are chemically modiﬁed molecules by hydroxylation of respectively A and B at position 19.In addition, these signatures were compared to the ones induced by
doxorubicin, an intercalating agent that is widely used to combat
various types of cancers [33] in order to evaluate spectral changes
induced by a molecule belonging to a different family.
2. Materials and methods
2.1. Compounds
Doxorubicin and hellebrin were purchased from Sigma-Aldrich S.A.
(Bornem, Belgium). Ouabain was purchased from Acros Organics (Geel,
Belgium). 19-hydroxy-2″-oxovoruscharinwas derived from 2″-oxovor-
uscharin, a cardenolide identiﬁed in the African plant Calotropis procera,
as detailed elsewhere [34]. In the same manner, 19-hydroxy-hellebrin
has been derived from hellebrin as detailed elsewhere [35]. The
structure of the CS's is presented in Fig. 1.
2.2. Cell culture
The human prostate cancer PC-3 (CRL-1435) cell line was obtained
from the American Type Culture Collection (ATCC, Manassas, VA) and
was maintained according to the supplier's instructions. Brieﬂy, the
cells were incubated at 37 °C in sealed (airtight) Falcon plastic dishes
(Nunc, Invitrogen SA, Merelbeke, Belgium) in a humidiﬁed atmo-
sphere of 5% CO2. The cells were kept in exponential growth in RPMI
medium supplemented with 10% fetal bovine serum (FBS), 1%
penicillin/streptomycin (an antibiotic/antimycotic solution), and 1%
kanamycin to prevent mycoplasms. Medium and FBS were purchased
fromGibco (Invitrogen, Merelbeke, Belgium). Penicillin/strepromycin
and kanamycin solutions came from Sigma-Aldrich SA, (Bornem,
Belgium). Drug concentrations used throughout this paper were the
IC50, deﬁned as the drug concentration required for decreasing the cell
population by half after 72 h of growth [34]. The medium was
replaced 24 h before delivering the drug to prevent any stress induced
by this handling.
For FTIR spectroscopy, cells were suspended after a ﬁve-minute
treatment with trypsin (0.5 g/L)/EDTA (0.2 g/L) buffer (Gibco,
Invitrogen SA, Merelbeke, Belgium). The reaction was stopped by
adding 1 ml of culture medium. The cells were pelleted by a 2-minuteoruscharin, C: Hellebrin, D: 19-hydroxy-hellebrin. A and C are natural products. B and D
Fig. 2. Series of infrared spectra of PC-3 cells untreated or exposed to different CS for a
period of time indicated in the right margin. Each spectrum was an independent
measure of about 3 104 cells. For each condition (CS, incubation time) 20 to 25 spectra
were recorded from at least 7 independent cell cultures. Untreated cell spectra were
recorded for each condition (time+drug). Among them, only 70 untreated cell spectra
were randomly selected and displayed here. For better readability, spectra were offset
along the absorbance axis.
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(NaCl, 0.9%) to ensure complete removal of trypsin and culture
medium. They were then suspended in the NaCl solution.Fig. 3. PCA scores on PC1 and PC2 computed for each drug including all exposure times.
Projections of untreated cells recorded for each incubation time were drawn in black ﬁlled ci
percentage of variance in the data explained by each PC is reported in brackets. 95% conﬁd2.3. In vitro overall growth determination
Overall cell growthwas assessed bymeans of the colorimetricMTT (3-
[4,5-dimethylthiazol-2yl]-diphenyltetrazolium bromide, Sigma, Bornem,
Belgium) assay, as detailed elsewhere [34]. The cells were incubated for
72 h in the presence or the absence (controls) of the tested compounds.
Drugconcentrations rangedbetween10−9 and10−5 M(2concentrations
per log unit). Experiments were carried out in sextuplicate.
2.4. FTIR spectroscopy
All measurements were carried out on a Bruker Equinox 55 FTIR
spectrometer (Bruker, Karlsruhe, Germany) equipped with a liquid
N2-refrigerated Mercury Cadmium Telluride detector. All spectra
were recorded by attenuated total reﬂection (for a review, see [36]). A
diamond internal reﬂection element was used on a Golden Gate
Micro-ATR from Specac (Orpington, UK). The angle of incidence was
45°. A 0.5 μL of the cell re-suspended in about twice the volume of the
pellet was deposited on the diamond crystal (about 3×104 cells per
smear). The samplewas quickly evaporated under N2 stream to obtain
a homogenous ﬁlm of whole cells, as ascertained by microscope
examination. The FTIR measurements were recorded between 4000
and 800 cm−1. Each spectrum was obtained by averaging 256 scans
recorded at a resolution of 2 cm−1. PC-3 cells were incubated in the
presence of CS during 5 different exposure times: 0 h, 6 h, 12 h, 24 hA: Ouabain, B: 19-hydroxy-2″-oxovoruscharin, C: Hellebrin, D: 19-hydroxy-hellebrin.
rcles. Squares: 6 h exposure to CS, diamond, 12 h; triangle, 24 h; empty circles, 36 h. The
ence ellipses are reported.
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harvested in exponential phase to avoid possible metabolic changes
occurring at the plateau [37]. Each condition was represented by at
least 7 independent culture samples, grown over a period of several
months, to obtain a good statistical sampling. From each culture ﬂask,
3 independent samples were harvested providing 3 independent
spectra from c.a. 3 104 cells. Overall around 20 to 25 spectra were
recorded for each incubation time and drug.Fig. 4. PCA loadings (PC1) obtained for each drug. A: Curves # 1, 2, 3, 4 are the PC1
respectively obtained fromthePCApresented inFig. 3A,B, C,D respectively. B.Hierarchical
classiﬁcation of PC1 displayed in Fig. 4A. Classiﬁcation was based on Euclidean distances.2.5. Data analysis
The FTIR data were preprocessed as follows. Water vapour
contribution was subtracted, and spectra were baseline-corrected
and normalized for equal area between 1765 and 950 cm−1. The
spectra were ﬁnally smoothed at a ﬁnal resolution of 4 cm−1 by
apodization of their Fourier transform by a Gaussian line.
Normality of the distribution of the absorbances was checked for
each group at every wavenumber by a Kolmogorov–Smirnov test by
comparison with a standard normal distribution, with a conﬁdence
level α=0.5% (not shown). The results demonstrated the normality
of absorbance distributions. For each culture run in the presence of a
CS, an additional culture of cells, free of any treatment, was grown in
parallel and analyzed. These untreated cells were ﬁrst used as control
for the quality of the cultures. If the IR spectra of a control displayed
any statistically signiﬁcant differences (α=0.5%) with previous
controls, the experiment was repeated. Second, untreated cells
spectra provided us with the reference FTIR ﬁngerprint. Overall,
more than 350 non treated cells spectra were recorded. Among them
only 70, randomly picked up, are displayed in Fig. 2 and used for
further analyses.
In IR spectra, each wavelength is a variable, i.e., about 1000
wavelengths are associated with biological molecule absorptions.
With at least nine spectra for each condition, the number of variables
submitted to statistical analysis quickly becomes extremely large.
Data are best handled after Principal Component Analysis (PCA),
which is an unsupervised statistical method that enables a reduction
of variables by building linear combinations of wavenumbers that
vary together [38]. Diagonalization of the covariance matrix of the
data provides new variables, the so-called principal components (PC)
holding all the correlated original variables on which original spectra
are ﬁnally projected. The ﬁrst principal component accounts for most
of the variance present in the data set; the second is built with the
residual variance and is uncorrelated to the ﬁrst one. The subsequent
components are constructed the same way and account for the
residual variance. In practice, almost all the variance of the original
data can be explained with three or four ﬁrst PC, reducing the
description of each spectrum to three or four numbers. Simulta-
neously, these weights allow an unsupervised classiﬁcation of the
spectra as such an observation does not suppose any a priori condition
on these groups [38]. In the analyses reported here, the collection of
spectra was mean-centred (the mean was removed from the
individual spectra).
Ward's linkage is another unsupervised method allowing hierar-
chical clustering of n groups with minimum loss of information. It is
based on the similarity of group members with respect to many
variables [39]. The grouping is based on the error sum of square
criterion (ESS). At each step of the grouping procedure, each possible
union is considered and the two items with the lower ESS are
grouped. The process is repeated until the number of groups is
reduced from n to 1 [40].
Correction of the spectra, Kolmogorov–Smirnov, Student t-tests,
PCA and hierarchical classiﬁcation were carried out by Kinetics, a
custom made program, running under Matlab 7.1. (Matlab, Math-
works Inc). Conﬁdence interval ellipses were computed with
Statistica (Statsoft Inc., Tulsa, U.S.A.).3. Results
3.1. PC-3 cell spectra treated with different cardiotonic steroids
IC50 values were measured on PC-3 cell line and were found to be
36 nM for ouabain, 9 nM for 19-hydroxy-2″-oxovoruscharin, 8 nM for
hellebrin, 8 nM for 19-hydroxy-hellebrin and 372 nM for doxorubicin.
For FTIR experiments, all compounds were used at their IC50
concentrations. This IC50 index represents the concentration that
reduces by 50% the growth of cancer cells after 72 h in the presence of
the drug. Fig. 2 displays the FTIR spectra of PC-3 cells grown in the
presence of the 4 CS at their IC50 as well as control spectra (untreated
PC-3 cancer cells).
3.2. PCA analysis
PCA statistical analyses including the spectra displayed in Fig. 2 are
reported in Fig. 3 for eachmolecule tested. Every point in the plot is the
projection of one of the original spectrum presented in Fig. 2. The
different incubation times are identiﬁed by a unique colour and shape,
and 95% conﬁdence ellipses were computed for each group. While the
cells exposed to the CS under study display a position on PC1 (the ﬁrst
principal component)/PC2 (the second principal component) projec-
tion distinct from the control untreated cells, signiﬁcant overlap
between spectra recorded at different incubation times is observed.
Interestingly, the action of CS that are hydroxylated in position 19 still
evolved continuously up to 36 h of treatmentwhile it stopped after 24 h
for their natural parent compounds. As only the ﬁrst principal
component demonstrated a signiﬁcant relation with treatment, the
ﬁrst principal component of each of the four PCA is presented on Fig. 4A.
These 4 principal components are relatively close in shape underlying
the similarity of the spectral changes induced by the 4 CSwith a positive
contribution of 1765–1400 cm−1 IR spectral range, and negative
contribution of region comprised between 1300 and 950 cm−1. The
features observed on PC1 located from 1765 to 1400 cm−1 can be
tentatively assigned to lipid and protein contributions [41–43] and the
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various protein side chains groups [42,44,45]. Small but signiﬁcant
differences between the CS under study can be observed between 1300
and 950 cm−1 where IR absorption bands mainly arise from poly-
saccharides or nucleic acids contributions [42,45]. A hierarchical
ascendant classiﬁcation of the PC1 clearly evidenced two subgroups,
one containing natural compounds and the other their counterparts
hydroxylated at position 19 (Fig. 4B).
In a second step PCA decomposition was used to compare the
effect of the different molecules after identical incubation times. Non
treated PC-3 prostate cancer cells were always included as reference.
As previously, 95% conﬁdence intervals were computed and drawn as
ellipses. Projections of spectra in the principal component space
deﬁned by PC1 (the ﬁrst principal component) and PC2 (the second
principal component) are reported on Fig. 5.
Fig. 5A illustrates metabolic modiﬁcations in PC-3 cells after 6 h of
treatment with CS: none of the CS induced signiﬁcant metabolic
modiﬁcations. Fig. 5B shows that distinctions between untreated PC-3
cells and those exposed to a given CS become apparent, particularly
along the ﬁrst principal component axis, while no drug-to-drug
difference could be evidenced. Fig. 5C illustrates that complete
separation between untreated and CS-treated PC-3 prostate cancer
cells has been achieved after 24 h of exposure of the cancer cells to the
CS. Again, no differences among the CS could be evidenced. Lastly,
after 36 h of incubation with the CS, Fig. 5D clearly reveals that theFig. 5. PCA scores on PC1 and PC2 computed for each incubation time including all drugs. P
A: 6 h; B: 12 h; C: 24 h; D: 36 h. I: Projections of untreated cell spectra are drawn as black ﬁll
red (□); III: 19-hydroxy-hellebrin, in blue (Δ). IV: Hellebrin, in purple (▲); V: Ouabain in
brackets. 95% conﬁdence ellipses are reported.two natural compounds, ouabain and hellebrin, caused similar
alterations of the IR cell spectra, while the two compounds
hydroxylated at position 19 were signiﬁcantly distinct from their
natural counterparts as well as between themselves. More precisely,
19-hydroxy-hellebrin (Fig. 5D) still affected protein region i.e. amide I
(1690–1620 cm−1), amide II (1570–1530) [42,43] and various CH2/3
deformation mode arising from proteins (1468–1455 cm−1) [42,45].
In addition to these areas, 19-hydroxy-2″-oxovoruscharin (Fig. 5B)
also strongly modiﬁed the carbonyl associated with phospholipids
(~1750–1700 cm−1) [41,42] and regions associated with nucleic
acids and glycosylations.
As spectrumprojection onto PC1 always showed the best separation
between untreated and CS incubated cells (Fig. 5), the ﬁrst principal
components of each PCA were displayed on Fig. 6. Overall, the PC1
obtained for each incubation time have similar shapes. Yet, some
signiﬁcant variations occurred in the IR region comprised between1300
and 950 cm−1, assigned to nucleic acids and sugars.
3.3. Incremental Student t-tests
Student t-tests were computed to compare successive incubation
times (6 h–untreated cells, 12 h–6 h, 24 h–12 h, 36 h–24 h). For each
molecule tested, Fig. 7 reports differences between mean spectra
obtained at two successive incubation times. Positive and negative
peaks are representative of molecules respectively more or lessrojection of spectra arising from untreated cells and those exposed to the drug during:
ed circles. II: 19-hydroxy-2″-oxovoruscharin treatment related cell spectra are drawn in
green (■). The percentage of variance in the data explained by each PC is reported in
Fig. 6. PCA loadings (PC1) obtained at each incubation time. A. Curves 1, 2, 3, 4 are the PC1
obtained in Fig. 5 A, B, C, D respectively. B. Hierarchical classiﬁcation of PC1 displayed in
Fig. 6A. Classiﬁcationwas basedonEuclideandistances between spectra. Abscissa units are
arbitrary as all spectra were rescaled.
Fig. 7. Incremental Student t-test. Each spectrum is the difference between two average spe
top for better readability. Thicker lines indicates wavenumbers statistically different (α=0.5
respectively calculated for 6 h–non treated cells, 12 h–6 h, 24 h–12 h, 36 h–24 h. A: Ouabain
the original spectra were rescaled, as detailed in Materials and methods. In turn, intensity
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Thicker curves indicate wavenumbers where the absorbance are
statistically different between the two conditions (Student t-test,
α=0.5%). Interestingly, during the ﬁrst 6 h, limited but statistically
different changes can be observed in the ester C O stretching of
phospholipids at 1740 cm−1 [41] aswell as the 1690–1650, 1450 cm−1
and 1230 cm−1 regions. Between 12 h and 6 h and even more
dramatically between 12 and 24 h large ampliﬁcation of the effects
observed earlier occurred. The intensity of these latter modiﬁcations
was also relatively large and almost all the IR regionswere affectedbyCS
treatment after 24 h. Yet, only small differences among CS were
observed in the difference proﬁles, indicating similar modiﬁcation of
the chemical composition of the cells during the ﬁrst 24 h. In the next
12 h, the picture changed drastically. During this latest period, only
small further spectral changes could be observed on PC-3 cell spectra
exposed to natural compounds. On the contrary 19-hydroxy-2″-
oxovoruscharin and 19-hydroxy-hellebrin induced further marked
spectral changes. 19-hydroxy-hellebrin still affected theprotein spectral
region as conﬁrmed by further modiﬁcation of amide I and II range. In
addition, 19-hydroxy-2″-oxovoruscharin also heavily affected the lipid
and nucleic acids/sugar spectral range.
3.4. Comparison of spectral modiﬁcations induced on PC-3 cells by
cardiotonic steroids and doxorubicin
In order to evaluate the relative speciﬁcity of the differences
among the CS observed above, PC-3 cells were treatedwith amolecule
belonging to a completely different family of anticancer drug:
doxorubicin. This drug is known to inhibit topoisomerase II and
induce lethal damage in DNA double strands that lead to apoptosis
[33]. As for CS treatment, PC-3 cells were incubated at doxorubicin
IC50 concentration. Differences in spectra between a 36 h-period ofctra obtained from successive pairs of experimental conditions. Spectra are offset to the
%) according to a Student t-test. Curves from the bottom to the top are difference spectra
, B: 19-hydroxy-2″-oxovoruscharin, C: Hellebrin, D: 19-hydroxy-hellebrin. Note that all
of the peaks can be directly compared.
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versus CS are illustrated in Fig. 8A. It can be observed that all spectral
signatures derived from a CS treatment were relatively similar in
comparison with the doxorubicin treatment signature. These various
spectra were compared by means of an ascendant hierarchical
classiﬁcation. Fig. 8B displays the result of this unsupervised
classiﬁcation. As expected, the effects of ouabain and hellebrin
spectral signature are highly similar, and 19-hydroxy-2″-oxovor-
uscharin and 19-hydroxy-hellebrin linked up further, while they are
still closer than doxorubicin-induced signature, underlying the
discrimination potential of the FTIR approach.4. Discussion
We demonstrate in the current study the potential usefulness of IR
spectroscopy to monitor metabolic modiﬁcations induced in cancer
cells by compounds displaying high chemical similarities. The human
PC-3 prostate cancer cell line was selected in the current study in
order to monitor, by means of FTIR analyses, CS-induced metabolic
effects because this cell line displays actual sensitivity to cardiotonic
steroids both in vitro [29] and in vivo [46].
FTIR monitoring of CS-induced metabolic effects in PC-3 prostate
cancer cells was carried out at the IC50 in vitro growth inhibitory
concentration calculated after 72 h of cell culturing in the absence
(control) or the presence of each CS. This experimental approach
enabled to ensure a maximum normalization process in terms of
compound concentrationwhenmonitoringmetabolic changes in PC-3
cancer cells. The choice of the drug concentration to be analyzed
remains indeed a critical issue as impact on cell metabolism may
depend on its concentration [47,48].Fig. 8. Comparison of the spectral changes induced by cardiotonic steroids and
doxorubicin. A: Student t-test between the mean spectrum obtained for each drug after
36 h incubation and non treated cell spectra. Spectra were offset to the top for better
readability. Thicker lines indicateswavenumbers statisticallydifferentwith a Student t-test
(α=0.5%). Difference spectra (drug minus control) are: 1. doxorubicin−control; 2. 19-
hydroxy-2″-oxovoruscharin−control; 3. 19-hydroxy-hellebrin−control; 4. hellebrin−
control; 5. ouabain−control. B. Hierarchical classiﬁcation of difference spectra computed
on the difference spectra shown in A. Classiﬁcation is based on Euclidean distances
between spectra. Abscissa units are arbitrary as all spectra were rescaled.The results reported here present two remarkable features.
First, the evolution of the spectra after 6, 12 and 24 h is essentially
characterized, for each CS molecule, by the same set of spectral
features, i.e. there is a single set of chemical modiﬁcations in the cell
(though affecting several types of molecules) which is continuously
ampliﬁed in time. This is unexpected as biologists are used to observe
cascades of different events, one triggering the next one when a
threshold is reached. This is not observed here, considering the time
period, the time resolution and the potential of FTIR to distinguish
chemical modiﬁcations in entire cells. While this lack of details
observed by FTIR is most certainly due to a lack of time and chemical
resolution, it is good news for diagnostic purpose as it indicates that
FTIR signatures are not strongly dependent on the incubation time. In
turn, these signatures are expected to be particularly robust.
The second remarkable feature observed in the data is the high
similarity of the spectral signatures determined for the four CS tested.
This feature emphasizes the robustness of the FTIR with respect to the
mechanism of action. In the present case, all cardiotonic steroids bind
to a single receptor, i.e. the Na+/K+-ATPase [3–5]. This robustness is
further highlighted when comparing the signatures of CS and
doxorubicin treatment. Doxorubicin was chosen because it is a well
characterized molecule known to induce a completely different
mechanism in cancer cells. It does not interact with the Na+/K+-
ATPase but is rather an inhibitor of topoisomerase II.
The FTIR approach revealed itself capable of evidencing subtle but
signiﬁcantly distinct metabolic modiﬁcations brought by the four CS.
The ﬁrst clear distinction appeared when comparing the two natural
CS (ouabain and hellebrin) with two hemisynthetic derivatives
chemically reduced in position 19 (19-hydroxy-2″-oxovoruscharin
and 19-hydroxy-hellebrin). Indeed, the metabolic modiﬁcations
brought by ouabain and hellebrin in PC-3 cancer cells evolved during
the ﬁrst 24 h of observation, and then stopped (Fig. 3 A,C). In contrast,
the metabolic modiﬁcations brought by the two hemisynthetic
derivatives continuously evolved during the 36 h of FTIR observation
carried out during the present study (Fig. 3 B,D). We did not proceed
with longer time of observation because during these ﬁrst 36 h-period
of FTIR analyses at IC50 we observed no PC-3 cell death as revealed by a
Trypan Blue assay (≥90% of PC-3 cells were alive in any experimental
condition; data not shown). In contrast, signiﬁcant PC-3 cell death
appeared after 48 h. At these IC50 concentrations, cancer cells die from
sustained autophagy and/or lysosomalmembrane permeabilization at
the 72 h of cell culturing in the presence of the CS [16,17].
In contrast to the two natural CS, i.e. ouabain and hellebrin,
metabolic modiﬁcations still occurred between the 24th and the 36th
h of PC-3 cell culturing in the presence of either 19-hydroxy-2″-
oxovoruscharin or 19-hydroxy-hellebrin (Fig. 7 B,D). The reason for
the lack of further activity after 36 h for natural compounds is unclear.
One hypothesis is that the natural molecules could be degraded either
in the culture medium or by the cells. Yet, the effect induced up to
24 h was not reversed as could be expected upon degradation and
return to normal metabolism. Indeed, reversal of the process would
have resulted in a difference spectrum between 36 and 24 h
incubation which would have been the mirror image of the 24–12 h
difference spectrum. The absence of such a spectral signature rather
suggests the alternative hypothesis that the cells reached a new
metabolic state allowing them to live in the presence of the natural CS,
even though growing at a slower pace.
In conclusion, a single set of spectral modiﬁcations characterizes
most of the effects of the four CS tested on PC-3 prostate cancer cells.
The same set of modiﬁcations is continuously ampliﬁed in the course
of the time to reach a plateau after 24 h for ouabain and hellebrin
where the cells appear to ﬁnd a new equilibrium. The effect of the 19-
hydroxylated compounds is further ampliﬁed up to 36 h. Even though
unique when compared to signature induced by an anticancer drug
from another family, subtle differences were recognized by FTIR
spectroscopy among the different CS and allowed to point out a
1094 R. Gasper et al. / Biochimica et Biophysica Acta 1802 (2010) 1087–1094deﬁnite particular effect of hydroxylation in position 19. These results
suggest that infrared spectroscopy could provide a unique signature of
cellular pathways triggered by themolecules tested and could offer an
objective selection criterion for drugs with original modes of action.
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